A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
PHASE2
This is a multi-center, randomized, double-blind, placebo-controlled study ...
Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
PHASE2
This is a Phase 2 Open-Label extension study to evaluate the long term safe...
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
PHASE3
The goal of this clinical trial is to evaluate the efficacy, safety and pha...
An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
PHASE1
This is an open-label, Phase 1 single-center study in approximately 40 subj...
Status
Completed
Location
Duke University School of Medicine / Dept. of Ophthalmology (Duke Eye Center)